A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 45/06 (2006.01) A61K 31/136 (2006.01) A61K 31/222 (2006.01) A61K 38/55 (2006.01) A61P 9/10 (2006.01)
Patent
CA 2376715
Left ventricular dysfunction is treated by a process, comprising: administering to a subject suffering from left ventricular remodeling a therapeutically effective amount of 5,6-dihydroxy-2-methylaminotetralin, or 5,6-diisobutyroyl-oxy-2-methyl-aminotetralin, or a pharmaceutically acceptable salt thereof in combination with an angiotensin-converting enzyme inhibitor.
On peut traiter le dysfonctionnement du ventricule gauche par un procédé consistant à administrer souffrant d'un remodelage du ventricule gauche une quantité à effet thérapeutique de 5,6-dihydéroxy-2-méthylaminotétraline, ou de 5,6-diisobutyroyl-oxy-2-méthyl-aminotétraline, l'un de leurs sels pharmacocompatibles, associés à un inhibiteur de l'enzyme de conversion de l'angiotensine.
Bongrani Stefano
Chiesi Paolo
Civelli Maurizio
Razzetti Roberta
Umile Alberto
Chiesi Farmaceutici S.p.a.
Kirby Eades Gale Baker
LandOfFree
Aminotetralin derivative for the therapy of cardiovascular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminotetralin derivative for the therapy of cardiovascular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminotetralin derivative for the therapy of cardiovascular... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1987430